Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Sanjog Sharma - Director Finance - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
DEF 14A
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceutical Industries (NYSE:TEVA) - Stock Price, News & Analysis - Simply Wall St
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Barcode No-Print Zone
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Price return performance. (Source: Can Teva (TEVA) Return to Growth in... | Download Scientific Diagram
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Credit Line and Bonds: Teva's Financial Catch | Ctech
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva Pharmaceuticals on Twitter: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva exits Massachusetts as Cambridge site falls victim to restructuring - Boston Business Journal
